Willingness of patients with chronic diseases to use telepharmacy services in Bandung City, West Java, Indonesia.

Publication date: Jul 11, 2025

The COVID-19 is known to be a severe pandemic that has accelerated the adoption of telepharmacy services. However, little is known about the current practices and willingness of patients with chronic diseases in the new-norm, specifically in a setting where such services are not properly established before the pandemic. The main objective of this study was to assess the current practices and willingness to use telepharmacy services as well as to identify factors associated with low willingness among patients with chronic diseases in Bandung City in Indonesia. A multisite cross-sectional survey was conducted in seven community health centers (CHCs) and one hospital in Bandung City, in Indonesia, which were selected based on the highest number of patients with chronic diseases. The survey utilized a purposive sampling method among patients with hypertension, dyslipidemia, diabetes, chronic obstructive pulmonary diseases (COPD), and/or chronic kidney diseases. Current practices and willingness to use telepharmacy services were evaluated through a paper-based questionnaire. Binary logistic regression analyses were performed to determine factors associated with low willingness to use telepharmacy services. Odds ratios (ORs) with 95% confidence intervals (CIs) were reported. A total of 443 patients with chronic diseases were participated, with most having hypertension. Overall, both current practices and willingness to use telepharmacy services were low. Factors associated with low willingness included being 50 years or older (OR = 3. 41; 95%CI = 1. 46-7. 97), inability to use the internet (OR = 3. 92; 95% CI = 1. 12-13. 76), using smartphones independently (OR = 3. 64; 95% CI = 1. 13-11. 72) or with assistance (OR = 6. 75; 95% CI = 1. 47-31. 07), and daily phone usage of less than an hour (OR = 5. 50; 95% CI = 1. 08-27. 89). The study indicated low practices and willingness to use telepharmcy services among patients with chronic diseases. As a result, patients-specific factors such as older age, inability to use the internet, as well as low daily use of smartphones that associated with the low willingness to use telepharmacy services should be considered in order to facilitate telepharmacy implementation in Indonesia.

Open Access PDF

Concepts Keywords
50years Adult
Diabetes Aged
Indonesia Chronic Disease
Pandemic Chronic diseases
Smartphones COVID-19
Cross-Sectional Studies
Female
Humans
Hypertension
Indonesia
Indonesia
Male
Middle Aged
Practices
SARS-CoV-2
Surveys and Questionnaires
Telemedicine
Telemedicine
Telepharmacy
Willingness

Semantics

Type Source Name
disease MESH chronic diseases
disease MESH COVID-19
disease MESH hypertension
disease MESH dyslipidemia
disease MESH chronic obstructive pulmonary diseases
disease MESH chronic kidney diseases
drug DRUGBANK Coenzyme M
disease IDO facility
drug DRUGBANK Nonoxynol-9
disease MESH emergency
disease MESH stroke
disease MESH hypercholesterolemia
disease MESH kidney failure
disease MESH cardiovascular diseases
disease MESH gastrointestinal diseases
disease MESH gout
disease MESH asthma
pathway KEGG Asthma
disease MESH tuberculosis
pathway KEGG Tuberculosis
pathway REACTOME Translation

Original Article

(Visited 4 times, 1 visits today)